VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹216 Cr | ₹171 Cr | ₹143 Cr | ₹116 Cr | ₹75 Cr |
What is the latest Appropriations of VENUS REMEDIES ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹216 Cr |
| Mar2024 | ₹171 Cr |
| Mar2023 | ₹143 Cr |
| Mar2022 | ₹116 Cr |
| Mar2021 | ₹75 Cr |
How is Appropriations of VENUS REMEDIES Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹216 Cr | 26.45 | |
| Mar2024 | ₹171 Cr | 19.66 | |
| Mar2023 | ₹143 Cr | 23.16 | |
| Mar2022 | ₹116 Cr | 54.06 | |
| Mar2021 | ₹75 Cr | - | |
Compare Appropriations of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,607.5 Cr | 10.6% | 67.2% | 334.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 10.6% |
67.2% |
334.2% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses